Global COVID-19 Vaccine Market Size, Share, Demand, Growth and Forecast Analysis Report 2021-2026

According to the MarkNtel Advisors' research report, "Global COVID-19 Vaccine Market Analysis, 2021," the market is expected to grow at an astronomical rate during 2021-26. The increasing presence of new manufacturers in developing countries, boost in government initiative by offering various financial aid to the pharma companies, and sturdy development of the vaccine due to surging emergence of the mutant virus among several countries are some of the factors promulgating the growth of the global market.

The factors restraining the market growth include high R&D costs, the negative impact of COVID-19 vaccines on human health, and the lack of supply chain infrastructure in low & middle-class countries (for vaccine storage & transportation.)

Get a sample copy of the report: https://www.marknteladvisors.com/query/request-sample/global-covid-19-vaccine-market.html

Key questions answered in the study
1. What are the current and future trends in the global COVID-19 Vaccine market?
2. How has the market been evolving in terms of end-user demand and application areas?
3. How has the competition been shaping across the countries, followed by their comparative factorial indexing?
4. What are the key growth drivers and challenges for the global COVID-19 Vaccine market?
5. What are the customer orientation, purchase behavior, and expectations from the global COVID-19 Vaccine market service provider across various regions?

Protein Subunit-Based Vaccine Holds the Considerable Market Share
Based on Vaccine Type, Protein Subunit-Based Vaccine secured a considerable market share in the Global COVID-19 Vaccine market in 2020. The usage of this vaccine is surging among patients with compromised immune responses. This vaccine does not use the live pathogen and hence, is considered very safe. The companies using protein subunit-based coronavirus vaccines are Novavax and Sanofi.

"Global COVID-19 Vaccine Market Analysis, 2021" offers comprehensive qualitative and quantitative insights on the market potential, key factors impacting the market growth, hotspots, and opportunities available for COVID-19 Vaccine providers across the globe. Moreover, the report also encompasses the key strategic imperatives for competitors' success and strategic factorial indexing measuring competitors' capabilities on 16 parameters. It will help companies formulate 'Go to Market' strategies and identify the blue ocean for its offerings.

Adult and Pediatrics Accounted for Considerable Market Share

Based on Patient Class, Adult and Pediatric accounted for considerable market share in the Global COVID-19 Vaccine market in 2020. This group of patient class relatively have higher immunity in comparison with senior citizens.

Moreover, the pediatric vaccine trial launches by pharma companies for children (as young as six months) and increasing Covid-19 patients (below 45 years) are the factors fueling the COVID-19 vaccine demand in the forecast period, reveals MarkNtel Advisors in their research report, "Global COVID-19 Vaccine Market Analysis, 2021."

For detailed analysis: https://www.marknteladvisors.com/research-library/global-covid-19-vaccine-market.html

According to MarkNtel Advisors, the major leading players in the global COVID-19 Vaccine market are AstraZeneca Plc, Johnson & Johnson Inc, Novavax, BioNTech, Moderna, Glaxo Smith Kline Plc, CSL Ltd., Abbott Laboratories, Daiichi Sankyo Company Ltd, Astellas Pharma Inc., Pfizer, Bharat Biotech, Serum Institute of India, etc.

Market Segmentation:
1. By Vaccine Type (Whole-microbe approach [Inactivated COVID-19 Vaccine, Live Attenuated COVID-19 Vaccine, Viral Vector-Based COVID-19 Vaccine], Subunit approach, Genetic Approach (Nucleic Acid Vaccine))
2. By Patient Class (Senior Citizens, Adults, Pediatrics)
3. By End-User (Academic & Research Institutes, Vaccination Centers, Clinics, Hospitals, Others)
4. By Region (North America, South America, Europe, Asia-Pacific, Middle East, and Africa)
5. By Country (U.S, Canada, Mexico, Brazil, Germany, France, The U.K, Italy, Spain, Russia, China, South Korea, Japan, India, GCC, South Africa)
6. By Competitors (AstraZeneca Plc, Johnson & Johnson Inc, Novavax, BioNTech, Moderna, Glaxo Smith Kline Plc, CSL Ltd., Abbott Laboratories, Daiichi Sankyo Company Ltd, Astellas Pharma Inc., Pfizer, Bharat Biotech, Serum Institute of India)

MarkNtel Advisors
Office No.106, H-160, Noida - 63, UP- 201301
India
Email: sales@marknteladvisors.com
Tel: +91 120 4185243
Website: https://www.marknteladvisors.com

MarkNtel Advisors is a leading research, consulting and data analytics firm that provides a wide range of strategic reports on diverse industry verticals to a substantial and varied client base that includes multinational corporations, financial institutions, governments, and individuals.

We specialize in niche industries and emerging geographies to support our clients in the formulation of strategies viz. Go to Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, trend analysis, etc. in around 15 industry verticals to enable our clients in identifying attractive investment opportunities and maximizing ROI through an early mover advantage.

This release was published on openPR.